FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for TRIUMEQ PD (abacavir sulfate, dolutegravir sodium, lamivudine) from ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• abacavir sulfate (abacavir sulfate)
• dolutegravir sodium (dolutegravir sodium)

Snippet

SUPPL AP for TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)